STRYKER CORP is an SEC registrant, filing under CIK 0000310764, classified as surgical and medical instruments and apparatus. It is grouped with Health Care companies on this site.
Footnote F1 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $331.15 to $332.11, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange… Full note on SEC EDGAR
Footnote F3 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $332.17 to $333.085, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange… Full note on SEC EDGAR
Footnote F4 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $333.16 to $334.14, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange… Full note on SEC EDGAR
Footnote F5 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $334.21 to $335.145, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange… Full note on SEC EDGAR
Footnote F6 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $335.15 to $336.145, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange… Full note on SEC EDGAR
Footnote F7 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $336.15 to $337.145, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange… Full note on SEC EDGAR
Footnote F8 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $337.15 to $338.13, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange… Full note on SEC EDGAR
Footnote F9 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $338.15 to $339.10, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange… Full note on SEC EDGAR
Footnote F10 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $331.74 to $332.00, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange… Full note on SEC EDGAR
Footnote F11 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $332.81 to $333.775, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange… Full note on SEC EDGAR
Footnote F12 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $333.81 to $334.20, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange… Full note on SEC EDGAR
Footnote F13 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $335.05 to $335.06, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange… Full note on SEC EDGAR
Footnote F14 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $336.20 to $337.14, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange… Full note on SEC EDGAR
Footnote F15 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $337.31 to $338.255, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange… Full note on SEC EDGAR
Footnote F16 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $338.30 to $339.295, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange… Full note on SEC EDGAR
Footnote F17 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $339.30 to $340.295, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange… Full note on SEC EDGAR
Footnote F18 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $340.30 to $341.27, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange… Full note on SEC EDGAR
Footnote F19 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $341.30 to $342.295, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange… Full note on SEC EDGAR
Footnote F20 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $342.32 to $343.29, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange… Full note on SEC EDGAR
Footnote F21 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $343.31 to $343.90, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange… Full note on SEC EDGAR
Footnote F1 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $336.255 to $336.304, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities &… Full note on SEC EDGAR
Footnote F2 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $305.59 to $305.665, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange… Full note on SEC EDGAR
Footnote F3 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $306.05 to $306.945, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange… Full note on SEC EDGAR
Footnote F4 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $307.06 to $307.76, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange… Full note on SEC EDGAR
Footnote F5 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $308.78 to $308.79, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange… Full note on SEC EDGAR
Footnote F1 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $310.35 to $310.995, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange… Full note on SEC EDGAR
Footnote F2 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $311.00 to $311.998, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange… Full note on SEC EDGAR
Footnote F3 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $312.00 to $312.995, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange… Full note on SEC EDGAR
Footnote F4 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $313.00 to $313.985, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange… Full note on SEC EDGAR
Footnote F5 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $314.00 to $314.985, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange… Full note on SEC EDGAR
Footnote F6 (price): The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $315.00 to $315.69, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange… Full note on SEC EDGAR
Footnote F1 (shares): Represents a grant of Restricted Stock Units (RSUs), which vest as to 100% of the shares on the earlier of (i) the date of the 2027 Annual Meeting of Shareholders of Stryker Corporation or (ii) May 6, 2027.
Footnote F2 (price): Each RSU represents a contingent right to receive one share of Stryker Common Stock.
Footnote F1 (shares): Represents a grant of Restricted Stock Units (RSUs), which vest as to 100% of the shares on the earlier of (i) the date of the 2027 Annual Meeting of Shareholders of Stryker Corporation or (ii) May 6, 2027.
Footnote F2 (price): Each RSU represents a contingent right to receive one share of Stryker Common Stock.
Footnote F1 (shares): Represents a grant of Restricted Stock Units (RSUs), which vest as to 100% of the shares on the earlier of (i) the date of the 2027 Annual Meeting of Shareholders of Stryker Corporation or (ii) May 6, 2027.
Footnote F2 (price): Each RSU represents a contingent right to receive one share of Stryker Common Stock.
Footnote F1 (shares): Represents a grant of Restricted Stock Units (RSUs), which vest as to 100% of the shares on the earlier of (i) the date of the 2027 Annual Meeting of Shareholders of Stryker Corporation or (ii) May 6, 2027. The Reporting Person voluntarily elected to defer receipt of the shares… Full note on SEC EDGAR
Footnote F2 (price): Each RSU represents a contingent right to receive one share of Stryker Common Stock.
Footnote F1 (shares): Represents a grant of Restricted Stock Units (RSUs), which vest as to 100% of the shares on the earlier of (i) the date of the 2027 Annual Meeting of Shareholders of Stryker Corporation or (ii) May 6, 2027.
Footnote F2 (price): Each RSU represents a contingent right to receive one share of Stryker Common Stock.
Footnote F1 (shares): Represents a grant of Restricted Stock Units (RSUs), which vest as to 100% of the shares on the earlier of (i) the date of the 2027 Annual Meeting of Shareholders of Stryker Corporation or (ii) May 6, 2027. The Reporting Person voluntarily elected to defer receipt of the shares… Full note on SEC EDGAR
Footnote F2 (price): Each RSU represents a contingent right to receive one share of Stryker Common Stock.
Footnote F1 (shares): Represents a grant of Restricted Stock Units (RSUs), which vest as to 100% of the shares on the earlier of (i) the date of the 2027 Annual Meeting of Shareholders of Stryker Corporation or (ii) May 6, 2027.
Footnote F2 (price): Each RSU represents a contingent right to receive one share of Stryker Common Stock.
Footnote F1 (shares): Represents a grant of Restricted Stock Units (RSUs), which vest as to 100% of the shares on the earlier of (i) the date of the 2027 Annual Meeting of Shareholders of Stryker Corporation or (ii) May 6, 2027.
Footnote F2 (price): Each RSU represents a contingent right to receive one share of Stryker Common Stock.
Footnote F1 (shares): Represents a grant of Restricted Stock Units (RSUs), which vest as to 100% of the shares on the earlier of (i) the date of the 2027 Annual Meeting of Shareholders of Stryker Corporation or (ii) May 6, 2027.
Footnote F2 (price): Each RSU represents a contingent right to receive one share of Stryker Common Stock.
Footnote F1 (shares): Represents a grant of Restricted Stock Units (RSUs) pursuant to the Stryker 2011 Long-Term Incentive Plan, which vest as follows: one-third of the shares on May 1, 2027; one-third of the shares on May 1, 2028; and the remaining one-third of the shares on May 1, 2029.
Footnote F2 (price): Each RSU represents a contingent right to receive one share of Stryker Common Stock.
Footnote F1 (shares): Represents a grant of Restricted Stock Units (RSUs) pursuant to the Stryker 2011 Long-Term Incentive Plan, which vest as follows: one-third of the shares on May 1, 2027; one-third of the shares on May 1, 2028; and the remaining one-third of the shares on May 1, 2029.
Footnote F2 (price): Each RSU represents a contingent right to receive one share of Stryker Common Stock.
Footnote F1 (shares): On March 11, 2026, the Reporting Person filed a Form 4 reporting the acquisition of 14,912 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2026 (the "Performance Stock Units"). The 430 shares being… Full note on SEC EDGAR
Footnote F1 (shares): On March 11, 2026, the Reporting Person filed a Form 4 reporting the acquisition of 14,912 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2026 (the "Performance Stock Units"). The 430 shares being… Full note on SEC EDGAR
Footnote F1 (shares): On March 11, 2026, the Reporting Person filed a Form 4 reporting the acquisition of 9,320 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2026 (the "Performance Stock Units"). The 269 shares being… Full note on SEC EDGAR
Footnote F1 (shares): On March 11, 2026, the Reporting Person filed a Form 4 reporting the acquisition of 50,332 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2026 (the "Performance Stock Units"). The 1,452 shares being… Full note on SEC EDGAR
Footnote F1 (shares): On March 11, 2026, the Reporting Person filed a Form 4 reporting the acquisition of 7,828 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2026 (the "Performance Stock Units"). The 225 shares being… Full note on SEC EDGAR
An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
STRYKER CORP (SYK) had 10 insider filings in the last 90 days, with the most recent on 2026-09-28. The full record for SYK runs to 83 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying SYK stock?
5 insider purchases of SYK were filed in the last 90 days, totaling $27K.
How many insiders are selling SYK stock?
22 insider sales of SYK were filed in the last 90 days, totaling $118.20M.
Where can I see SYK SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects SYK Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
House of Representatives Periodic Transaction Reports from 2024. Senate filings are not included yet. The full history of SYK beside its insider purchases is in the Congress Tracker.
Ronda E. Stryker - Director
Spencer S. Stiles - Officer
Rajeev Suri - Director
Tatum Lisa M. Skeete - Director
Emmanuel Perez Maceda - Director
Thomas H. Kean, Jr.Republican, NJ-07
